On March 19, 2026, Roche Pharma India signed a Memorandum of Understanding (MoU) with the National Institute of Pharmaceutical Education and Research (NIPER) Raebareli. The partnership aims to foster a strong industry-academia link, supporting India’s emergence as a global hub for biopharmaceutical innovation.
Strategic areas of collaboration:
-
Bridging Academic and Industry Gaps: The initiative focuses on equipping students and faculty with real-world insights into the evolving pharmaceutical landscape and complex regulatory frameworks.
-
Diverse Educational Programs: Key offerings include a certificate program in regulatory affairs, guest lectures by industry experts on AI in drug development, and specialized healthcare innovation seminars.
-
Research and Talent Support: The agreement features scholarship-cum-industry exposure opportunities for students and faculty immersion programs designed to update academic knowledge with industrial practices.
-
Expanding Collaborative Networks: This marks Roche’s second major academic partnership in 2026 (following NIPER Mohali in February), aimed at building a highly skilled workforce and a more resilient healthcare system.
This collaboration is expected to transform academic excellence into a global competitive advantage for India’s biopharma sector through advanced technologies and innovative research.